Recent Headlines
Within Biotechnology
Mitegen Announces Distribution Agreement with Mexico Diffractia S. de R.L.de C.V.
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Mexico Diffractia S. de R.L.de C.V. of... - February 24, 2012 - MiTeGen, LLC
Nanion Introduces the Orbit 16 – a Pioneering Device for Parallel Lipid Bilayer Recordings
Nanion announces the introduction of a completely new product line for efficient analysis of bilayer-reconstituted ion channels and nanopores. The first of these, the Orbit 16, allows for automated formation of, and recordings from 16 bilayers in parallel, combining efficient data generation and ultra-high data quality. The Orbit 16 takes the pain out of bilayer recordings and facilitates efficient data generation through 16 parallel recordings. - February 24, 2012 - Nanion Technologies GmbH
AnaSpec Offers Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection
AnaSpec, EGT Group offers one of the world’s largest selections of Histone GO® (catalog) peptides. The peptides include sequences containing modified amino acids such as methylated (Me1, Me2 and Me3) Lysine; phosphorylated Threonine (pThr) or Serine (pSer); deiminated Arginine (Cit). - February 23, 2012 - AnaSpec, EGT Group
OsoBio Appoints Marian Meyer Director of Labs
Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
New Propulsion Method for Low-Cost Microsatellites
Stevens doctoral candidate Kyle Godin has received the Abe M. Zarem Award for research on a low-cost thruster that promises to allow universities and independent researchers to launch craft, potentially democratizing space exploration. - February 19, 2012 - Stevens Institute of Technology
Red Cedar Technology and MSC Software Form Strategic Partnership
HEEDS MDO software integrates easily with MSC Adams, Nastran, Marc - February 18, 2012 - Red Cedar Technology
AnaSpec Offers Special Pricing for MOG (1-125) Recombinant Proteins
AnaSpec, EGT the first provider of commercial MOG recombinant proteins is pleased to offer a 50% discount off on MOG (1-125) recombinant proteins through the month of February, 2012 to US and Canadian customers. Please mention code “rMOG50%” when ordering to get the discount. AnaSpec's... - February 16, 2012 - AnaSpec, EGT Group
Biomedica Immunoassays Appoints ALPCO Diagnostics as Its Exclusive Distributor in Canada
ALPCO Diagnostics was recently appointed as Biomedica Immunoassays' exclusive distributor in Canada. - February 15, 2012 - ALPCO
BioPharm Systems to Host Webinar on Using Oracle Health Sciences Empirica Topics to Document Your Signal Management Process
Leading provider of Oracle's clinical trial, data, and drug safety software will discuss why and how Empirica Topics should be implemented and used to strengthen an organization’s pharmacovigilance systems and processes. - February 15, 2012 - BioPharm Systems
BioPharm Systems to Host Webinar on Preparing Clinical Trial Data for Reporting and Analysis
Leading provider of Oracle’s clinical trial, data, drug safety, and pharmacovigilance systems will discuss and demonstrate a better way to prepare clinical trial data for reporting and analysis. - February 15, 2012 - BioPharm Systems
AnaSpec Introduces SensoLyte® Factor Xa Activity Assays – Industry’s First Fluorimetric Kits
AnaSpec, EGT Group is pleased to announce the release of the industry first fluorimetric Factor Xa activity assays - The SensoLyte® 520 Factor Xa Assay Kit and the SensoLyte® Rh110 Factor Xa Assay Kit. The SensoLyte® 520 Factor Xa Assay Kit employs a FRET (5-FAM/QXL™ 520)... - February 15, 2012 - AnaSpec, EGT Group
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing
Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
Bioo Scientific’s New ELISAs Increase Speed and Sensitivity of Aflatoxin M1 Analysis in Milk
Bioo Scientific launched two new MaxSignal® Aflatoxin M1 ELISA Kits; one with increased speed and other with increased sensitivity. - February 13, 2012 - Bioo Scientific
Stevens Professor Ting Yu Receives AFOSR Grant to Study Entanglement in Quantum Systems
Stevens Professor Ting Yu has received an AFOSR grant to study entanglement in quantum systems, potentially bringing quantum technology closer to reality. - February 10, 2012 - Stevens Institute of Technology
Dr. Thomas Wakeman Appointed Chair of Marine Group at Transportation Research Board
Dr. Thomas Wakeman of Stevens Institute of Technology has been appointed chair of the Transportation Research Board (TRB), a division of the National Research Council, which serves as an independent adviser to the President, the Congress and federal agencies on scientific and technical questions of national importance. - February 10, 2012 - Stevens Institute of Technology
Stevens Professor Darinka Dentcheva Appointed to SIAM Review Editorial Board
Dr. Dentcheva, an expert on stochastic optimization for efficient energy production as well as risk-averse models for economic systems and medical treatment, has been appointed to the editorial board of the SIAM Review, the most influential journal in the field of applied mathematics. - February 09, 2012 - Stevens Institute of Technology
SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event
SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
MaxSignal® Malachite Green/LMG ELISA is Included in the USDA’s Chemistry Laboratory Guidebook
The USDA added the MaxSignal® Malachite Green ELISA to the Chemistry Laboratory Guidebook as the recommended method for screening fish for Malachite Green contamination. - February 06, 2012 - Bioo Scientific
AnaSpec Offers Antibodies Against the Hexa-His and GFP Tags
The introduction of tags, whether short peptides (6X-His, DYKDDDDK, c-myc) or proteins (green fluorescent protein – GFP, glutathione-s-transferase – GST) into recombinant proteins aids in the characterization, localization or purification of the recombinant expressed protein.1-3 As a... - February 03, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Calcein AM for Live Cell Staining
Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells.1-2 It is widely used for determining cell viability since the fluorescence intensity of calcein is... - February 02, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Atrial Natriuretic Peptides in GO® Collection
AnaSpec, EGT Group provides a wide range of GO® (catalog) natriuretic peptides for use in research laboratories. Their selection of atrial natriuretic peptides (ANPs) include the biologically active 1-28 amino acid peptide (human/porcine or rat sequences); shorter ANP fragments; and Biotin, FAM... - February 02, 2012 - AnaSpec, EGT Group
Bio3 Research S.r.l. Completed Its Acquisition of the Full Ownership of All the Patents in Its Portfolio Concerning HMGB1
Bio3 Research S.r.l. (Milan/Italy) is pleased to announce that it has completed its acquisition of the full ownership of all the patents in its portfolio concerning HMGB1 (High Mobility Group Box 1). HMGB1 patents have been granted to Bio3 Research in the USA, Europe, Japan, Australia, Mexico,... - February 02, 2012 - Bio3 Research S.r.l.
Advanced Cancer Therapeutics Chief Scientific Officer to Present Preclinical Data on Glycolysis Inhibitors at World Cancer Metabolism Summit
Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Dr. Gilles Tapolsky, ACT’s Chief Scientific Officer, has been selected to present at the World Cancer Metabolism Summit to be held February 1 – February 2, 2012 in Washington, D.C. - February 01, 2012 - Advanced Cancer Therapeutics
U.S. Army’s Presidio of Monterey DFMWR Incorporates Proactive Solution to Bacteria
Long-lasting antimicrobial technology will fight bacteria growth 24/7 for up to 90 days with one application. ecoSolv Distribution, LLC and the United States Army’s Presidio of Monterey in California today announced the installation’s facilities will in part be treated with... - January 31, 2012 - ecoSolv Distribution LLC
Colorado’s Bioscience Industry Leaders and Legislators Focus on 2012 Initiatives at Annual "BioScience Day at the Capitol"
Colorado BioScience Association (CBSA) is hosting its fourth annual "BioScience Day at the Capitol" on February 2. The CBSA is building upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education. - January 30, 2012 - Colorado BioScience Association
BioResource International Supports the Inter-Faith Food Shuttle
BioResource International, Inc. (www.briworldwide.com) is proud to announce their continuing support of the Inter-Faith Food Shuttle (www.foodshutttle.org), through their sponsorship of the 18th Annual Taste of Hope Gala (http://tasteandblossoms.org/). The gala, benefiting the Inter-Faith Food... - January 29, 2012 - BioResource International, Inc
BioResource International, Inc. Presents Latest Research at the International Poultry Expo
Scientists from the Agricultural biotechnology company BioResource International, Inc. (www.briworldwide.com) presented their latest research at the International Poultry Science Forum held in conjunction with the International Poultry Expo in Atlanta from January 23-26, 2012... - January 29, 2012 - BioResource International, Inc
Novus Biologicals Added as New Preferred Vendor for the University of Washington
Novus Biologicals is excited to be a preferred vendor for the University of Washington. Novus’ extensive product line will soon be added to the UW online ordering system, and all UW researchers will now receive 5% off any order. Novus Biologicals is committed to developing and maintaining... - January 28, 2012 - Novus Biologicals
NovaTeinBio Now Offering Wider Range of ELISA Kit Testing Solutions
Cambridge, MA based biological reagents provider NovaTeinBio has recently announced that have added to the company’s exceptional selection of ELISA kit products. The company has made this move in order to continue to provide one of North America’s largest selections of ELISA kit... - January 27, 2012 - Novatein Biosciences
AnaSpec Expands SensoLyte® 520 Renin Assay Kits Collection
AnaSpec, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit now provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using their proprietary 5-FAM/QXL™ 520 fluorescence resonance... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® α-Synuclein ELISA Assay
AnaSpec, EGT Group is pleased to announce the release of an ultrasensitive ELISA assay for quantitatingα-synuclein. The SensoLyte® α-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-Synuclein amount in cell and... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Offers Speedy 28-Day Custom Polyclonal Antibody Service
When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - January 25, 2012 - AnaSpec, EGT Group
Red Cedar Technology Welcomes Robert R. Ryan as President and CEO
Former Board Chairman transitions into new role on company’s leadership team. - January 25, 2012 - Red Cedar Technology
BioPharm Systems to Host Webinar on the Ins and Outs of CTMS Data Migration
Leading provider of Oracle's clinical trial, data, and drug safety software will discuss how the data in an existing clinical trial management system should be handled when migrating to a new application. - January 22, 2012 - BioPharm Systems
New, Interactive Social Media Fundraising Campaign, Arrest ALS, Launched
Innovative fundraising concept leverages social media to raise money and awareness to end ALS. - January 22, 2012 - ALS Therapy Development Institute
Pratt & Miller Engineering Enters Sales Agent Agreement with Red Cedar Technology
Industry-leading engineering firm will resell HEEDS MDO software. - January 19, 2012 - Red Cedar Technology
NovaTeinBio Advancing Research with New CD Antigen Solutions
Boston based biological reagents provider NovaTeinBio has recently announced to their client base that they will now be providing more CD (clusters of differentiation) antigen products than ever before. These new additions come as research companies across America look to specialists such as... - January 19, 2012 - Novatein Biosciences
AnaSpec Includes Ghrelin and Obestatin Peptides in GO® Collection
AnaSpec, EGT Group, a leading provider of integrated proteomic and genomic solutions, offers a wide range of ghrelin and obestatin GO® (catalog) peptides for research use. In 1999, Kojima and his group (1) reported the discovery of a growth hormone secretagogue that is involved in the release... - January 19, 2012 - AnaSpec, EGT Group
AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit
AnaSpec, EGT Group, the provider of ultra-sensitive fluorimetric SensoLyte® line of assay kits is pleased to announce the release of the SensoLyte® Fluorimetric NADP/NADPH Assay Kit. This assay is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NAD/NADH. - January 19, 2012 - AnaSpec, EGT Group
Arthritis and Bacterial Infection Research Nabs Win for Stevens Student
Stevens undergrad demonstrates how bacteria infection plays a role in arthritis. - January 19, 2012 - Stevens Institute of Technology
AnaSpec Highlights Its Proprietary HiLyte Fluor™ Dye Collection
AnaSpec, EGT Group’s proprietary HiLyte Fluor™ dyes are a series of excellent fluorescent labeling dyes with fluorescence emissions that span the full visible and near infrared spectrum. The hydrophilic property of most of the HiLyte Fluor™ dyes makes conjugations to protein... - January 17, 2012 - AnaSpec, EGT Group
Nanion Celebrates Its 10th Anniversary - Still with a Strong Focus on New Innovations
Today, Nanion celebrates 10 years of innovation, scientific product development and successful roll-outs of several product families. Nanion is a success story of organic, revenue-based company growth and dedicated young professionals. - January 17, 2012 - Nanion Technologies GmbH
CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul and the Ministry of Knowledge Economy
CrystalGenomics, Inc. (KOSDAQ: CRYSTAL [083790]), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF). This is the third time within... - January 16, 2012 - CrystalGenomics, Inc.
John Quackenbush to Speak at CHI’s Bioinformatics & Cancerinformatics Conference, February 21-23, San Francisco, CA
Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. - January 12, 2012 - Cambridge Healthtech Institute
SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.
Aciont® To Present on VisulexTM Technologies at the 4th Ocular & Drug Discovery Conference
Aciont Inc. announced today that both Kongnara Papangkorn, Research Director and Sarah Abdulla Molokhia, Scientific Research Consultant, will present on Aciont’s Visulex technologies at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012,... - January 12, 2012 - Aciont Inc.
Autoscribe Launches US Operation
The formation of Autoscribe Informatics Inc., a wholly owned subsidiary of Autoscribe Ltd, has been announced. Based in Falmouth, MA, USA, it gives Autoscribe, the developers of Matrix software products, a much stronger presence in the US and Canadian markets. Zumatrix Inc. operated as... - January 12, 2012 - Autoscribe Informatics
CrystalGenomics to Present at J.P. Morgan Healthcare Conference on January 12
CrystalGenomics, Inc. (KOSDAQ: CRYSTAL (083790)), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that Joong Myung Cho, Ph.D., President & CEO, will present an overview of CrystalGenomics’ business strategy and an update on its development pipeline on... - January 11, 2012 - CrystalGenomics, Inc.
NEXTflex™ Modules Lower the Cost of Next Generation Sequencing Sample Prep
Bioo Scientific recently launched the NEXTflex™ DNA, ChIP-Seq, and PCR-Free Modules, which were designed to lower the cost of library prep for high throughput users. Modules are available for each step in the library preparation protocol including end repair, adenylation, ligation and PCR. - January 06, 2012 - Bioo Scientific
Bioo Scientific Simplifies the Analysis of Apoptotic Bodies with the D-Pop™ Kit
Bioo Scientific launched the D-Pop™ Kit to capture apoptotic bodies from cell-free fluids and to extract DNA from them offering a non-invasive source of biomarkers for the diagnosis and prognosis of diseases. - January 05, 2012 - Bioo Scientific